Antioxidant role of amyloid β protein in cell-free and biological systems: Implication for the pathogenesis of Alzheimerdisease

Free Radical Biology and Medicine

Volumn 56, Issue , 2013, Pages 184-192

  Sinha, Maitrayee ^a   Bhowmick, Pritha ^a   Banerjee, Anindita ^a   Chakrabarti, Sasanka ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Alzheimer disease; Amyloid peptide; Antioxidant; Free radicals; Mitochondria; Reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ASCORBIC ACID; BENZOIC ACID; BRAIN PROTEIN; CARBOXYLIC ACID; COUMARIN; HYDROGEN PEROXIDE; HYDROXYL GROUP; IRON; RADICAL;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN MITOCHONDRION; CELL FREE SYSTEM; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION RESPONSE; HYDROXYLATION; IN VITRO STUDY; IRON CHELATION; LIPID OXIDATION; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; BRAIN; CELL-FREE SYSTEM; MITOCHONDRIA; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 84874115680     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.09.036     Document Type: Article

References (83)

1. M.A. Smith, C.A. Rottkamp, A. Nunomura, A.K. Raina, and G. Perry Oxidative stress in Alzheimer's disease Biochim. Biophys. Acta 1502 2000 139 144
2. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
3. R. Pamplona, E. Dalfo, V. Ayala, M.J. Bellmunt, J. Prat, I. Ferrer, and M. Portero-Otin Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation: effects of Alzheimer disease and identification of lipoxidation targets J. Biol. Chem. 280 2005 21522 21530
4. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat. Rev. Mol. Cell Biol. 2 2007 101 112
5. B. De Strooper Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process Physiol. Rev 90 2010 465 494
6. P.I. Moreira, X. Zhu, Q. Liu, K. Honda, S.L. Siedlak, P.L. Harris, M.A. Smith, and G. Perry Compensatory responses induced by oxidative stress in Alzheimer disease Biol. Res. 39 2006 7 13
7. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, and M.A. Smith Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 759 767
8. A. Nunomura, G. Perry, M.A. Pappolla, R.P. Friedland, K. Hirai, S. Chiba, and M.A. Smith Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome J. Neuropathol. Exp. Neurol. 59 2000 1011 1017
9. S. Varadarajan, S. Yatin, M. Aksenova, and D.A. Butterfield Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity J. Struct. Biol. 130 2000 184 208
10. I.V.J. Murray, L. Liu, H. Komatsu, K. Uryu, G. Xiao, J.A. Lawson, and P.A. Axelsen Membrane mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid β proteins J. Biol. Chem. 282 2007 9335 9345
11. J.N. Keller, Z. Pang, J.W. Geddes, J.G. Begley, A. Germeyer, G. Waeg, and M.P. Mattson Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal J. Neurochem. 69 1997 273 284
12. S. Dhitavat, E.R. Riverac, E. Rogers, and T.B. Shea Differential efficacy of lipophilic and cytosolic antioxidants on generation of reactive oxygen species by amyloid-β J. Alzheimers Dis. 3 2001 525 529
13. R.J. Mark, M.A. Lovell, W.R. Markesbery, K. Uchida, and M.P. Mattson A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide J. Neurochem. 68 1997 255 264
14. D.G. Smith, R. Cappai, and K.J. Barnham The redox chemistry of the Alzheimer's disease amyloid β peptide Biochim. Biophys. Acta 1768 2007 1976 1990
15. X. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein, R.C. Scarpa, M.P. Cuajungco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi, and A.I. Bush The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction Biochemistry 38 1999 7609 7616
16. 2 catalytically but quench hydroxyl radicals Biochemistry 47 2008 11653 11664
17. R. Baruch-Suchodolsky, and B. Fischer Abeta 40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems Biochemistry 48 2009 4354 4370
18. A.C. Andorn, and R.N. Kalaria Factors affecting pro- and anti-oxidant properties of fragments of the b-protein precursor (bPP): implication for Alzheimer's disease J. Alzheimers Dis. 2 2000 69 78
19. M.F. Walter, P.E. Mason, and R.P. Mason Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions Biochem. Biophys. Res. Commun. 233 1997 760 764
20. A. Kontush, C. Berndt, W. Weber, V. Akopyan, S. Arlt, S. Schippling, and U. Beisiegel Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma Free Radic. Biol. Med. 30 2001 119 128
21. K. Jomova, D. Vondrakova, M. Lawson, and M. Valko Metals, oxidative stress and neurodegenerative disorders Mol. Cell. Biochem. 345 2010 91 104
22. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell, and W.R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J. Neurol. Sci. 158 1998 47 52
23. M. Nakamura, N. Shishido, A. Nunomura, M.A. Smith, G. Perry, Y. Hayashi, K. Nakayama, and T. Hayashi Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron Biochemistry 46 2007 12737 12743
24. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine 4th edition 2007 Clarendon Press Oxford
25. J.R. Hoidal Reactive oxygen species and cell signaling Am. J. Respir. Cell. Mol. Biol. 25 2001 661 663
26. 2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-β peptide Biochemistry 46 2007 2881 2891
27. K.J. Barnham, V.B. Kenche, G.D. Ciccotosto, D.P. Smith, D.J. Tew, X. Liu, K. Perez, G.A. Cranston, T.J. Johanssen, I. Volitakis, A.I. Bush, C.L. Masters, A.R. White, J.P. Smith, R.A. Cherny, and R. Cappai Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease Proc. Natl. Acad. Sci. USA 105 2008 6813 6818
28. M. Sinha, P. Behera, P. Bhowmick, K. Banerjee, S. Basu, and S. Chakrabarti Aging promotes amyloid beta peptide induced mitochondrial dysfunctions in rat brain: a molecular link between aging and Alzheimer's disease J. Alzheimers Dis. 27 2011 753 765
29. H 3rd. Levine Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution Protein Sci 2 1993 404 410
30. J.M. Gutteridge Ferrous-salt-promoted damage to deoxyribose and benzoate: the increased effectiveness of hydroxyl-radical scavengers in the presence of EDTA Biochem. J. 243 1987 709 714
31. Y. Manevich, K.D. Held, and J.E. Biaglow Coumarin-3-carboxylic acid as a detector for hydroxyl radicals generated chemically and by γ radiation Radiat. Res. 148 1997 580 591
32. Q. Chen, E.J. Vazquez, S. Moghaddas, C.L. Hoppel, and E.J. Lesnefsky Production of reactive oxygen species by mitochondria: central role of complex III J. Biol. Chem. 38 2003 36027 36031
33. 2 release from activated human leukocytes using a dihydroxyphenoxazine derivative J. Immunol. Methods 202 1997 133 141
34. S. Jana, M. Sinha, D. Chanda, T. Roy, K. Banerjee, S. Munshi, B.S. Patro, and S. Chakrabart Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease Biochim. Biophys. Acta 1812 2011 663 673
35. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
36. H. Chakraborty, S.N. Ray, and S. Chakrabarti Lipid peroxidation associated protein damage in rat brain crude synaptosomal fraction mediated by iron and ascorbate Neurochem. Int. 39 2001 311 317
37. R.L. Levine, J.A. Williams, E.R. Stadtman, and E. Shacter Carbonyl assays for determination of oxidatively modified proteins Methods Enzymol. 233 1994 346 357
38. K.A. Cockell, and B. Belonje The carbonyl content of specific plasma proteins is decreased by dietary copper deficiency in rats J. Nutr. 132 2002 2514 2518
39. J. Long, F. Gao, L. Tong, C.W. Cotman, B.N. Ames, and J. Liu Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L-carnitine Neurochem. Res. 34 2009 755 763
40. L.J. Yan, E.S. Christians, L. Liu, X. Xiao, R.S Sohal, and I.J Benjamin Mouse heat shock transcription factor 1deficiency alters cardiac redox homeostasis and increases mitochondrial oxidative damage EMBO J. 21 2002 5164 5172
41. P.C. Hinkle Oxygen proton and phosphate fluxes and stoichiometries G.C. Brown, C.E. Cooper, Bioenergetics: a Practical Approach 1995 IRL Press Oxford 1 15
42. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin-phenol reagent J. Biol. Chem. 193 1951 265 275
43. B. Halliwell, and J.M. Gutteridge Oxygen toxicity, oxygen radicals, transition metals and disease Biochem. J. 219 1984 1 14
44. R. Baruch-Suchodolsky, and B. Fischer Soluble amyloid beta(1-28)-(I)/copper(II)/iron(II) complexes are potent antioxidants in cell-free copper systems Biochemistry 47 2008 7796 7806
45. 2 J. Biol. Chem. 277 2002 40302 40308
46. F.E. Ali, F. Separovic, C.J. Barrow, R.A. Cherny, F. Fraser, A.I. Bush, C.L. Masters, and K.J. Barnham Methionine regulates copper/hydrogen peroxide oxidation products of Aβ J. Pept. Sci. 11 2005 353 360
47. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid beta peptide concentration as predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862
48. R.A. Cherny, J.T. Legg, C.A. McLean, D.P. Fairlie, X. Huang, C.S. Atwood, K. Beyreuther, R.E. Tanzi, C.L. Masters, and A.I. Bush Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion J. Biol. Chem. 274 1999 23223 23228
49. C. Caspersen, N. Wang, J. Yao, A. Sosunov, X. Chen, J.W. Lustbader, H.W. Xu, D. Stern, G. McKhann, and S.D. Yan Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease FASEB J. 19 2005 2040 2041
50. M. Manczak, T.S. Anekonda, E. Henson, B.S. Park, J. Quinn, and P.H. Reddy Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Hum. Mol. Genet. 15 2006 1437 1449
51. J.X. Chen, and S.S. Yan Role of mitochondrial amyloid-β in Alzheimer's disease J. Alzheimers Dis. 20 2010 S569 S578
52. K. Broersen, F. Rousseau, and J. Schymkowitz The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res. Ther. 2 2010 1 12
53. X. Hu, S.L. Crick, G. Bu, C. Frieden, R.V. Pappu, and J.M. Lee Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide Proc. Natl. Acad. Sci. USA 106 2009 20324 20329
54. 1-42 reduces iron-induced toxicity in rat cerebral cortex J. Neurosci. Res. 73 2003 316 323
55. M.P. Murphy How mitochondria produce reactive oxygen species Biochem. J. 417 1 2009 1 13
56. 2 production by membrane potential and NAD(P)H redox state J. Neurochem. 86 2003 1101 1107
57. L. Kussmaul, and J. Hirst The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria Proc. Natl. Acad. Sci. USA 103 2006 7607 7612
58. G. Paradies, G. Petrosillo, M. Pistolese, and F.M. Ruggiero Reactive oxygen species mitochondrial electron transport complex I activity through oxidative cardiolipin damage Gene 286 2002 135 141
59. H.P. Indo, M. Davidson, H.C. Yen, S. Suenaga, K. Tomita, T. Nishii, M. Higuchi, Y. Koga, T. Ozawa, and H.J. Majima Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage Mitochondrion 7 2007 106 118
60. H.H. Szeto Mitochondria-targeted peptide antioxidants: novel neuroprotective agents AAPS J. 8 2006 619 642
61. K. Zou, J.S. Gong, K. Yanagisawa, and M. Michikawa A novel function of monomeric amyloid β protein serving as an antioxidant molecule against metal-induced oxidative damage J. Neurosci. 22 2002 4833 4841
62. R. Subramaniam, T. Koppal, M. Green, S. Yatin, B. Jordan, J. Drake, and D.A. Butterfield The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid β-peptide (25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease Neurochem. Res. 23 1998 1403 1410
63. L. Canevari, A.Y. Abramov, and M.R. Duchen Toxicity of amyloid β peptide: tales of calcium, mitochondria, and oxidative stress Neurochem. Res. 29 2004 637 650
64. M. Johnstone Gearing, A. J.; Miller, K. M. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced J. Neuroimmunol. 93 1999 182 193
65. A. Kontush Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease Free Radic. Biol. Med. 31 2001 1120 1131
66. S. Hauptmann, I. Scherping, S. Dröse, U. Brandt, K.L. Schulz, M. Jendrach, K. Leuner, A. Eckert, and W.E. Müller Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice Neurobiol. Aging 30 2009 1574 1586
67. J. Xu, S. Chen, G. Ku, S.H. Ahmed, J. Xu, H. Chen, and C.Y. Hsu Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation J. Cereb. Blood Flow Metab. 21 2001 702 710
68. V. Rhein, G. Baysang, S. Rao, F. Meier, A. Bonert, F. Müller-Spahn, and A. Eckert Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells Cell. Mol. Neurobiol. 29 2009 1063 1071
69. L. Pagani, and A. Eckert Amyloid-beta interaction with mitochondria Int. J. Alzheimers Dis. 2011 925050
70. C.M. Rodrigues, S. Sola, M.A. Brito, C.D. Brondino, D. Brites, and J.J. Moura Amyloid β-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate Biochem. Biophys. Res. Commun. 281 2001 468 474
71. M.J. Calkins, M. Manczak, P. Mao, U. Shirendeb, and P.H. Reddy Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease Hum. Mol. Genet. 20 2011 4515 4529
72. Y.H. Hsiao, P.S. Chen, S.H. Yeh, C.H. Lin, and P.W. Gean N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5activity in cultured cortical neurons J. Neurosci. Res. 86 2008 2685 2695
73. P. Chonpathompikunlert, J. Han, K. Toh, H. Isoda, and Y.TEMPOL Nagasaki protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity Eur. J. Pharmacol. 650 2011 544 549
74. X. Huang, C.S. Atwood, R.D. Moir, M.A. Hartshorn, R.E. Tanzi, and A.I. Bush Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Aβ peptides J. Biol. Inorg. Chem. 9 2004 954 960
75. L. Xiao, D. Zhao, W.H. Chan, M.M. Choi, and H.W. Li Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots Biomaterials 31 2010 91 98
76. D.J. Tew, S.P. Bottomley, D.P. Smith, G.D. Ciccotosto, J. Babon, M.G. Hinds, C.L. Masters, R. Cappai, and K.J. Barnham Stabilization of neurotoxic soluble β-sheet-rich conformations of the Alzheimer's disease amyloid-β peptide Biophys. J. 94 2008 2752 2766
77. M. Hirohata, K. Ono, H. Naiki, and M. Yamada Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro Neuropharmacology 49 2005 1088 1099
78. E. Tamagno, P. Bardini, A. Obbili, A. Vitali, R. Borghi, D. Zaccheo, M.A. Pronzato, O. Danni, M.A. Smith, G. Perry, and M. Tabaton Oxidative stress increases expression and activity of BACE in NT2 neurons Neurobiol. Dis. 10 2002 279 288
79. P.H. Frederikse, D. Garland, J.S. Zigler Jr, and J. Piatigorsky Oxidative stress increases production of β-amyloid precursor protein and β-amyloid (Aβ) in mammalian lenses, and Aβ has toxic effects on lens epithelial cells J. Biol. Chem. 271 1996 10169 10174
80. C. Goldsbury, I.T. Whiteman, E.V. Jeong, and Y.A. Lim Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons Aging Cell 7 2008 771 775
81. S. Mandel, T. Amit, O. Bar-Am, and M.B. Youdim Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents Prog. Neurobiol. 82 2007 348 360
82. X. Dai, Y. Sun, Z. Gao, and Z. Jiang Copper enhances amyloid-β peptide neurotoxicity and non β-aggregation: a series of experiments conducted upon copper-bound and copper-free amyloid-β peptide J. Mol. Neurosci. 41 2010 66 73
83. R. Naylor, A.F. Hill, and K.J. Barnham Is covalently crosslinked Aβ responsible for synaptotoxicity in Alzheimer's disease? Curr. Alzheimers Res. 5 2008 533 539